OPEN END TURBO OPTIONSSCHEIN - DEXCOM Stock

DE000JQ8DBL2

Market Closed - Börse Stuttgart 15:48:18 2024-05-17 EDT
1.75 ^EUR	+6.06%

Current month	-15.05%
1 month	+16.67%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes

Chart DEXCOM, INC.

Chart OPEN END TURBO OPTIONSSCHEIN - DEXCOM

Latest news about DEXCOM, INC.

DexCom : Human Rights Statement	05-08	PU
Glutality Powered by StrideMD Announces Integration with Dexcom to Enhance Remote Diabetes Care with CGM Technology	04-30	CI
Wall Street: the worst week of 2024 is followed by the best	04-26	CF
Morgan Stanley Adjusts DexCom's Price Target to $132 From $122	04-26	MT

More news

Quotes 5-day view

Date	Price	Change
24-05-17	1.75	+6.06%
24-05-16	1.65	-9.84%
24-05-15	1.83	-17.19%
24-05-14	2.21	-4.33%
24-05-13	2.31	+7.94%

Delayed Quote Börse Stuttgart

Last update May 17, 2024 at 03:48 pm

More quotes

Static data

Product type	Knock-Out ohne Stop Loss
Buy / Sell	PUT
Underlying	DEXCOM, INC.
Issuer	J.P. Morgan
WKN	JQ8DBL
ISIN	DE000JQ8DBL2
Date issued	2022-10-06
Strike	149.7 $
Maturity	Unlimited
Parity	10 : 1
Emission price	6.04 €
Emission volume	N/A
Settlement	Barausgleich
Currency	EUR

Technical Indicators

Highest since issue	7.06 €
Lowest since issue	0.69 €
Spread	0.01 €
Spread %	0.58%

Company Profile

DexCom, Inc. specializes in the design, manufacture and marketing of continuous glucose monitoring (CGM) systems for people with diabetes and healthcare providers. The company provides an implantable device for continuous measurement of blood glucose levels and an external transmitter to which the sensor transmits glucose levels at specified intervals. The United States accounts for 72.5% of net sales.

Sector

More about the company

Ratings for DexCom, Inc.

Trading Rating

Investor Rating

ESG Refinitiv

B-

More Ratings

Consensus: DexCom, Inc.

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

131.4 USD

Average target price

151.2 USD

Spread / Average Target

+15.12%

Consensus